Splenic function in sickle cell anemia patients in Qatif, Saudi Arabia

A 70-yr-old woman presented with a severe haemorrhagic diathesis due to an acquired factor X deficiency. A plasma infusion study showed that exogenous factor X was eliminated very effectively from the patient's circulation. A bone marrow biopsy was consistent with plasma cell dyscrasia. Neither an abdominal fat biopsy nor the bone marrow biopsy confirmed an amyloidosis, although clinically no other diagnosis seemed possible. Treatment with intermittent chemotherapy, consisting of vincristine, cytoxan and prednisone, yielded definite clinical and laboratory improvement.

show abstract

Successful treatment of an acquired haemorrhagic diathesis due to factor X deficiency with chemotherapy

Jäger¹,

Bieger²,

Castel

et al. 2001

European J of Haematology

View full text Add to dashboard Cite

show abstract

scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.

Contact Info

customersupport@researchsolutions.com

10624 S. Eastern Ave., Ste. A-614

Henderson, NV 89052, USA

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Blog Terms and Conditions API Terms Privacy Policy Contact Cookie Preferences Do Not Sell or Share My Personal Information

Made with 💙 for researchers

Part of the Research Solutions Family.

Splenic function in sickle cell anemia patients in Qatif, Saudi Arabia

Cited by 1 publication

References 0 publications

Successful treatment of an acquired haemorrhagic diathesis due to factor X deficiency with chemotherapy

Successful treatment of an acquired haemorrhagic diathesis due to factor X deficiency with chemotherapy

Contact Info

Product

Resources

About